Sexual Health Literacy Scale (SHLS)

May 2, 2024 updated by: Nurdan Demirci

Development of the Sexual Health Literacy Scale

According to the World Health Organization, sexual health is a state of well-being related to sexuality as a whole, not just the absence of disease or dysfunction or disability. sexual health; It requires a positive and respectful attitude, free from sexual coercion and discrimination, free of violence, enjoyable and safe experiences. It obliges the respect, protection and fulfillment of the sexual rights of every individual. sexual health; includes a safe and respectful framework free from violence and discrimination; it covers not only the reproductive period, but every age period; different sexual identities and forms of sexual expression, as well as livable and critical gender values, roles, expectations and power dynamics. Insufficient information, difficult access to health services and lack of a guiding structure; It negatively affects young individuals' ability to take responsible decisions with good knowledge about sexuality during their sexual development. Information is obtained from channels where erroneous and incorrect information transfer is intense, and the ways of accessing this information play an important role in the spread of sexual myths in society. Based on all these reasons; This study aimed to develop the Sexual Health Literacy Scale.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

400

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

It is very difficult to determine what kind of universe individuals over the age of 18 create and to reach the representative group even if it is determined. For this reason, rather than the criterion of representing the universe, it was based on creating a heterogeneous sample group by considering various age groups in a "fit for purpose" way. In this direction, the "snowball sampling" technique, which is one of the non-random sampling types, was preferred. Snowball sampling is a sampling method used in cases where it is difficult to reach the desired population and sample, including quantitative research, especially qualitative research, and the desired sampling frame does not include a large number of sample individuals.

Description

Inclusion Criteria:

  • Individuals over the age of 18 who are willing to participate in the study, without psychiatric illness,
  • No physical or mental disability
  • Able to speak and understand Turkish.

Exclusion Criteria:

  • Not willing to participate in the study, with psychiatric illness,
  • Physically and mentally handicapped
  • 18 years and under,
  • Does not speak Turkish

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
scale development
Time Frame: 3 month

The data will be collected with the online data collection tool created by the researchers through the software called google forms. During data collection, the e-mail address of the researchers will be indicated on the form so that the questions of the participants can be answered by the researchers. You will be informed that filling out the data collection form will take an average of 10 minutes for each participant.

In addition, in order to evaluate the test-retest reliability of the scale, data collection tools will be sent to at least 30 randomly selected individuals from the sample two weeks after the first data collection.

3 month
test-retest reliability of the scale
Time Frame: Retest( later 2 weeks)
In order to evaluate the test-retest reliability of the scale, data collection tools will be sent to at least 30 randomly selected individuals from the sample two weeks after the first data collection. Therefore, after the pre-application, the scale will be applied to 400 people within the scope of the calculated sample, and then, two weeks later, at least 50 people will be re-applied from the individuals to whom the same scale was applied.
Retest( later 2 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Rüveyda Ölmez Yalazı, PhDc, Marmara University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 4, 2024

Primary Completion (Estimated)

May 30, 2024

Study Completion (Estimated)

December 30, 2024

Study Registration Dates

First Submitted

April 5, 2023

First Submitted That Met QC Criteria

April 18, 2023

First Posted (Actual)

April 20, 2023

Study Record Updates

Last Update Posted (Actual)

May 6, 2024

Last Update Submitted That Met QC Criteria

May 2, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2023.shls.olmezyalazi

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sexual Behavior

Clinical Trials on data collection group

3
Subscribe